Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Teva Pharma Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (179)
ARTG (99)
Prescription medicine registration (27)
Australian Public Assessment Report (AusPAR) (7)
Prescription medicine decision summary (3)
Section 14, TGO91 consent (2)
Designation or determination (1)
Prescription medicine evaluation (1)

Date

2026 (12)
2025 (32)
2024 (120)
2023 (13)
2022 (13)
2021 (57)
2020 (23)
2019 (8)
2018 (5)
2017 (6)
2016 (18)
2015 (2)
2012 (1)
2011 (4)
2006 (3)
1995 (2)

Search

Sponsor content

319 result(s) found, displaying 171 to 180

RIVAROXABAN-TEVA rivaroxaban 10 mg tablet bottle (369549)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 10 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet bottle (369548)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 20 mg tablet bottle (369545)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 20 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 20 mg tablet blister pack (369547)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 20 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 10 mg tablet blister pack (369539)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 10 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 15 mg tablet bottle (369535)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 15 mg tablet bottle.
RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet blister pack (369533)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 2.5 mg tablet blister pack.
RIVAROXABAN-TEVA rivaroxaban 15 mg tablet blister pack (369538)

17 May 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for RIVAROXABAN-TEVA rivaroxaban 15 mg tablet blister pack.
ABIRATERONE-TEVA (Teva Pharma Australia Pty Ltd)

23 August 2023

Prescription medicine registration

Active ingredients: Abiraterone acetate.
ABIRATERONE-TEVA (Teva Pharma Australia Pty Ltd)

16 August 2023

Prescription medicine registration

Active ingredients: Abiraterone acetate.

Pages

First page
Previous page
…
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Page 20
Page 21
Page 22
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.